A drug interaction study evaluating the pharmacokinetics and toxicity of sorafenib in combination with capecitabineINFANTE, Jeffrey R; JONES, Suzanne F; BENDELL, Johanna C et al.Cancer chemotherapy and pharmacology. 2012, Vol 69, Num 1, pp 137-144, issn 0344-5704, 8 p.Article

Early detection, prevention and management of cutaneous adverse events due to sorafenib: Recommendations from the Sorafenib Working GroupBRACARDA, Sergio; RUGGERI, Enzo Maria; MONTI, Marcello et al.Critical reviews in oncology/hematology. 2012, Vol 82, Num 3, pp 378-386, issn 1040-8428, 9 p.Article

Hand-Foot Syndrome (Hand-Foot Skin Reaction, Palmar-Plantar Erythrodysesthesia): Focus on Sorafenib and SunitinibLIPWORTH, Adam D; ROBERT, Caroline; ZHU, Andrew X et al.Oncology. 2009, Vol 77, Num 5, pp 257-271, issn 0030-2414, 15 p.Article

Risk of hand-foot skin reaction with the novel multikinase inhibitor regorafenib: a meta-analysisVISWANATH REDDY BELUM; SHENHONG WU; LACOUTURE, Mario E et al.Investigational new drugs. 2013, Vol 31, Num 4, pp 1078-1086, issn 0167-6997, 9 p.Article

Experience with sorafenib and adverse event managementBELLMUNT, Joaquim; EISEN, Timothy; FISHMAN, Mayer et al.Critical reviews in oncology/hematology. 2011, Vol 78, Num 1, pp 24-32, issn 1040-8428, 9 p.Article

Hand-foot skin reaction in patients treated with sorafenib : a clinicopathological study of cutaneous manifestations due to multitargeted kinase inhibitor therapyYANG, C.-H; LIN, W.-C; CHUANG, C.-K et al.British journal of dermatology (1951). 2008, Vol 158, Num 3, pp 592-596, issn 0007-0963, 5 p.Article

Lack of Association Between Excretion of Sorafenib in Sweat and Hand-Foot Skin ReactionJAIN, Lokesh; GARDNER, Erin R; FIGG, William D et al.Pharmacotherapy. 2010, Vol 30, Num 1, pp 52-56, issn 0277-0008, 5 p.Article

Hand foot skin reaction in cancer patients treated with the multikinase inhibitors sorafenib and sunitinibLACOUTURE, M. E; REILLY, L. M; GERAMI, P et al.Annals of oncology. 2008, Vol 19, Num 11, pp 1955-1961, issn 0923-7534, 7 p.Article

The risk of hand-foot skin reaction to axitinib, a novel VEGF inhibitor: a systematic review of literature and meta-analysisFISCHER, Alyssa; SHENHONG WU; HO, Alan L et al.Investigational new drugs. 2013, Vol 31, Num 3, pp 787-797, issn 0167-6997, 11 p.Article

Clinical Management and Case Reports for the Treatment of Hepatocellular Carcinoma With SorafenibFRENETTE, Catherine T; FREDERICK, Richard Todd; GISH, Robert G et al.Journal of clinical gastroenterology. 2011, Vol 45, Num 8, pp 733-737, issn 0192-0790, 5 p.Article

Risk of mucocutaneous toxicities in patients with solid tumors treated with sorafenib: an updated systematic review and meta-analysisABDEL-RAHMAN, Omar; FOUAD, Mona.Expert review of anticancer therapy. 2014, Vol 14, Num 6, pp 751-760, issn 1473-7140, 10 p.Article

Genetic Predisposition of Hand-Foot Skin Reaction After Sorafenib Therapy in Patients With Hepatocellular CarcinomaJOO HO LEE; CHUNG, Young-Hwa; KWANG CHEOL KOH et al.Cancer. 2013, Vol 119, Num 1, pp 136-142, issn 0008-543X, 7 p.Article

Development and validation of a prediction index for hand-foot skin reaction in cancer patients receiving sorafenibDRANITSARIS, G; VINCENT, M. D; YU, J et al.Annals of oncology. 2012, Vol 23, Num 8, pp 2103-2108, issn 0923-7534, 6 p.Article

A randomized multicenter phase II trial on the efficacy of a hydrocolloid dressing containing ceramide with a low-friction external surface for hand-foot skin reaction caused by sorafenib in patients with renal cell carcinomaSHINOHARA, N; NONOMURA, N; ETO, M et al.Annals of oncology. 2014, Vol 25, Num 2, pp 472-476, issn 0923-7534, 5 p.Article